Compare CVS Health Corp (CVS) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Alphabet Inc Class A — how do they compare? CVS Health Corp trades at $107.04 (market cap $135.48B), while Alphabet Inc Class A trades at $369.38 (market cap $4.37T). The key difference: Alphabet Inc Class A is far larger — about 32.3× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | GOOGL | |
|---|---|---|
Market Cap | $135.48B | $4.37T |
Sector | Health | Media |
52-Week High | $106.18 | $402.62 |
52-Week Low | $58.75 | $182.00 |
Enterprise Value | $202.02B | $4.34T |
Dividend Yield | 2.51% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Alphabet (GOOGL) trades at $367.14, up 4.15% today, with a neutral technical signal and strong fundamentals. The stock shows robust profitability with a 37.92% net margin and consistent earnings beats, including Q1 2026 EPS of $5.11 versus $2.64 expected. Revenue grew to $402.84B in 2025, and operating cash flow surged to $164.71B. Analysts are overwhelmingly bullish with an 85.19% buy rating and a $431.78 consensus price target. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube subscription price increases.
The outlook for GOOGL remains positive, supported by AI expansion and solid financials, but risks include antitrust scrutiny and market volatility. The stock offers upside to analyst targets, though investors should monitor competitive pressures and regulatory developments that could impact growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
